Pre‐existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma
Authors:
Open Access
- 29 May 2019
- journal article
- research article
- Published by Wiley in Journal of Diabetes
- Vol. 11 (12) , 993-1001
Abstract
Background Diabetes is a risk factor for various cancers, but its prognostic role in renal cell carcinoma (RCC) is controversial and understudied. The current study investigated the prognostic value of type 2 diabetes mellitus (T2DM) in RCC patients. Methods We reviewed the clinicopathological and follow‐up data of 451 RCC patients who received radical or partial nephrectomy at the First Hospital of Shanxi Medical University from 2013 to 2018. To evaluate the association of T2DM with RCC clinicopathological parameters, the Kaplan‐Meier method was used for survival estimates and Cox regression for univariate and multivariate analyses. A subgroup of T2DM patients was analyzed for the effect of laparoscopic versus open surgery on postoperative recurrence rates. Results Of the 451 patients, 74 (16.4%) had T2DM. These patients were older and had a higher body mass index, higher incidence rates of hypertension and cardiovascular morbidity, a higher rate of laparoscopic surgery, and smaller neoplasms (all P<0.05). T2DM patients exhibited shorter overall survival (OS), cancer‐specific survival (CSS) and recurrence‐free survival (RFS) (P=0.009, P=0.043, P=0.008, respectively) than patients without T2DM. T2DM (HR=3.391, 95% CI: 1.458‐7.886, P=0.005) and Fuhrman grade (HR=2.542, 95% CI: 1.115‐5.795, p=0.026) were independent predictors of OS, and T2DM was an independent predictor of CSS (HR=4.637, 95% CI: 1.420‐15.139, P=0.011) and RFS (HR=3.492, 95% CI: 1.516‐8.044, P=0.003). Among the 74 T2DM patients, different surgical approaches were irrelevant to RFS (P=0.728). Conclusions RCC patients with preexisting T2DM have a shorter OS and higher recurrence rate and mortality risk than those without T2DM.Keywords
This publication has 39 references indexed in Scilit:
- Multi-Institutional Analysis of Localized Renal Cell Carcinoma that Demonstrates the Impact of Diabetic Status on Prognosis After NephrectomyAnnals of Surgical Oncology, 2013
- Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitroBMC Cancer, 2013
- Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysisDiabetes/Metabolism Research and Reviews, 2012
- Diabetes and Risk of Renal Cell CarcinomaJournal of Cancer, 2012
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2011
- Risk of cancer in a large cohort of U.S. veterans with diabetesInternational Journal of Cancer, 2010
- Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancerCancer Causes & Control, 2010
- Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysisInternational Journal of Cancer, 2007
- History of treated hypertension and diabetes mellitus and risk of renal cell cancerAnnals of Oncology, 2006
- Pathology and Genetics of Tumours of the Urinary System and Male Genital OrgansHistopathology, 2005